Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;32(1):1-12.
doi: 10.18176/jiaci.0769.

Molecular Allergy Diagnosis in Clinical Practice: Frequently Asked Questions

Affiliations
Review

Molecular Allergy Diagnosis in Clinical Practice: Frequently Asked Questions

O Luengo et al. J Investig Allergol Clin Immunol. 2022 Feb.

Abstract

Considerable progress has been made in the field of molecular biology in recent years, enabling the study of sensitization to the individual components of an allergenic source, a practice that has been termed molecular allergy diagnosis (MD) or component-resolved diagnosis (CRD). The present review provides the clinician with a practical approach to the use of MD by answering questions frequently asked by physicians on how MD can help improve the diagnosis of allergy in daily clinical practice. The article is divided into 3 sections. First, we provide a brief review of the importance for the clinician of knowing the main allergens in the different allergenic sources, their structure, and their in vitro cross-reactivity before approaching MD (section A). Second, we review the usefulness of MD in clinical practice (section B) and answer frequently asked questions on the subject. Finally, section C addresses the interpretation of MD and its integration with other tools available for the diagnosis of allergy.

Keywords: Allergen component; Component-resolved diagnosis (CRD); Cross-reactivity; Genuine sensitization; Molecular allergy diagnosis (MD).

PubMed Disclaimer